Wikidata entity: Q27077698
C₃₁H₅₃N₃O₄₉S₈ (P274)
Quantities
| P4250 | defined daily dose | 2.5 |
| P2067 | mass | 1506.951 |
| P3780 | active ingredient in | ... | Q29004851 (Arixtra) | Arixtra |
| P233 | canonical SMILES | String | COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284667 (LiverTox toxicity likelihood category E) | LiverTox toxicity likelihood category E |
| P2175 | medical condition treated | ... | Q815819 (atrial fibrillation) | atrial fibrillation |
| P2175 | medical condition treated | ... | Q220570 (pulmonary embolism) | pulmonary embolism |
| P2175 | medical condition treated | ... | Q1423167 (phlebitis) | phlebitis |
| P2175 | medical condition treated | ... | Q261327 (thrombosis) | thrombosis |
| P2175 | medical condition treated | ... | Q377978 (thrombophlebitis) | thrombophlebitis |
| P1748 | NCI Thesaurus ID | String | C73142 | ??? |
| P129 | physically interacts with | ... | Q416336 (Serpin family C member 1) | Serpin family C member 1 |
| P6802 | related image | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Fondaparinux.svg | ??? |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q415366 (tirofiban) | tirofiban |
| P769 | significant drug interaction | ... | Q416232 (prasugrel) | prasugrel |
| P769 | significant drug interaction | ... | Q420542 (ticagrelor) | ticagrelor |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q416485 (Streptokinase) | Streptokinase |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q420262 (rivaroxaban) | rivaroxaban |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q1644947 (tenecteplase) | tenecteplase |
| P769 | significant drug interaction | ... | Q1851701 (dalteparin) | dalteparin |
| P769 | significant drug interaction | ... | Q2295855 (eptifibatide) | eptifibatide |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q307088 (abciximab) | abciximab |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q3655338 (cangrelor) | cangrelor |
| P769 | significant drug interaction | ... | Q20817139 (iloprost) | iloprost |
| P769 | significant drug interaction | ... | Q45769835 (alteplase) | alteplase |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q105969996 (enoxaparin) | enoxaparin |
| P769 | significant drug interaction | ... | Q110969665 (urokinase) | urokinase |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q410237 (clopidogrel) | clopidogrel |
| P769 | significant drug interaction | ... | Q412050 (prostacyclin) | prostacyclin |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q414462 (apixaban) | apixaban |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q906280 (direct Xa inhibitor) | direct Xa inhibitor |
| P2868 | subject has role | ... | Q50316187 (antithrombin) | antithrombin |
Why not click here or view trends?
log id: 1835261